27.06.2014 • News • Brenntag • chemicals distribution • distribution

New Cooperation Between Brenntag and Epsan Deutschland

Brenntag will be taking over the distribution of polyamide 6 and polyamide 66 compounds (PA6 and PA66) in Germany for Epsan Deutschland. PA6 and PA66 compounds belong to the engineering plastics family. The products are distributed under the brand names Eplamid and Eplon and are used in the automotive, mechanical engineering, electrical, electronics, medicine, household devices and other sectors.

"Epsan's compounds are a very valuable addition to our portfolio and round out our range of engineering plastics and high-performance polymers in Germany," said Frank Dahlke, Head of Plastics Sales at Brenntag.

Adrian Kaminski, Managing Director of Epsan Deutschland, added: "Epsan's excellent know-how in the field of polyamides combined with Brenntag's outstanding market position promises significant advantages as regards local availability, together with first-class technical support in all regions of Germany."

Epsan's headquarters and production facilities are based in Turkey.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Top-Feature

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.